The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ballance David James since 2018.
The trader's CIK number is 1755432.
At the time of the last reporting, Ballance David James was the VP, Research and Sci. Affairs of Phasebio Pharmaceuticals Inc. (stock ticker symbol PHAS).
Also see all insider trading activities at Phasebio Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | PHAS | 1,000 | $3,940 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-12-13 | PHAS | Buy | 1,000 | 3.94 | 3,940 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ballance David James (VP, Research and Sci. Affairs of Phasebio Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.